SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-22-023855
Filing Date
2022-10-11
Accepted
2022-10-11 06:01:24
Documents
3
Period of Report
2022-11-10

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A rvph20220930_def14a.htm DEF 14A 389491
2 pc01.jpg GRAPHIC 243069
3 pc02.jpg GRAPHIC 219232
  Complete submission text file 0001437749-22-023855.txt   1027254
Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38634 | Film No.: 221301979
SIC: 2834 Pharmaceutical Preparations